Extracellular HSPA1A promotes the growth of hepatocarcinoma by augmenting tumor cell proliferation and apoptosis-resistance

Cancer Letters

Volumn 317, Issue 2, 2012, Pages 157-164

  Wu, Feng Hua ^a   Yuan, Ye ^a   Li, Dong ^a   Liao, Sheng Jun ^a   Yan, Bin ^a   Wei, Jing Jing ^a   Zhou, Yuan Hong ^a   Zhu, Jian Hua ^a   Zhang, Gui Mei ^a   Feng, Zuo Hua ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Extracellular HSPA1A; NF B; TLR2; TLR4; Tumor

Indexed keywords

HEAT SHOCK PROTEIN 70; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN HSPA1A; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR PROMOTION;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; HEP G2 CELLS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, NUDE; NF-KAPPA B; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TRANSPLANTATION, HETEROLOGOUS; TUMOR BURDEN;

EID: 84856603638     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.11.020     Document Type: Article

References (37)

1. Srikrishna G., Freeze H.H. Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer. Neoplasia 2009, 11:615-628.
2. Edwards J.G., Swinson D.E., L Jones J., Muller S., Waller D.A., O'Byrne K.J. Tumor necrosis correlates with angiogenesis and is a predictor of poor prognosis in malignant mesothelioma. Chest 2003, 124:1916-1923.
3. Edwards J.G., Swinson D.E., Jones J.L., Muller S., Waller D.A., O'Byrne K.J. Necrosis and hypoxia in invasive breast carcinoma. Breast Cancer Res. Treat. 2003, 81:61-69.
4. Koukourakis M.I., Giatromanolaki A., Sivridis E., Bougioukas G., Didilis V., Gatter K.C., Harris A.L. Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis. Br. J Cancer 2003, 89:877-885.
5. DeVries A.F., Kremser C., Hein P.A., Griebel J., Krezcy A., Ofner D., Pfeiffer K.P., Lukas P., Judmaier W. Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 2003, 56:958-965.
6. Wheeler D.S., Chase M.A., Senft A.P., Poynter S.E., Wong H.R., Page K. Extracellular Hsp72, an endogenous DAMP, is released by virally infected airway epithelial cells and activates neutrophils via Toll-like receptor (TLR)-4. Respir. Res. 2009, 10:31-43.
7. Schmitt E., Gehrmann M., Brunet M., Multhoff G., Garrido C. Intracellular and extracellular functions of heat shock proteins: repercussions in cancer therapy. J. Leukoc. Biol. 2007, 81:15-27.
8. Basu S., Binder R.J., Suto R., Anderson K.M., Srivastava P.K. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int. Immunol. 2000, 12:1539-1546.
9. Bausero M.A., Gastpar R., Multhoff G., Asea A. Alternative mechanism by which IFN-gamma enhances tumor recognition: active release of heat shock protein 72. J. Immunol. 2005, 175:2900-2912.
10. Kampinga H.H., Hageman J., Vos M.M., Kubota H., Tanguay R.M., Bruford E.A., Cheetham M.E., Chen B., Hightower L.E. Guidelines for the nomenclature of the human heat shock proteins. Cell Stress Chaperones 2009, 14:105-111.
11. Asea A. Initiation of the immune response by extracellular Hsp72: chaperokine activity of Hsp72. Curr. Immunol. Rev. 2006, 2:209-215.
12. Sato Y., Goto Y., Narita N., Hoon D.S. Cancer cells expressing Toll-like receptors and the tumor microenvironment. Cancer Microenviron. 2009, 15:205-214.
13. Kelly M.G., Alvero A.B., Chen R., Silasi D.A., Abrahams V.M., Chan S., Visintin I., Rutherford T., Mor G. TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer. Cancer Res. 2006, 66:3859-3868.
14. Goto Y., Arigami T., Kitago M., Nguyen S.L., Narita N., Ferrone S., Morton D.L., Irie R.F., Hoon D.S. Activation of Toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors. Mol. Cancer Ther. 2008, 7:3642-3653.
15. Pidgeon G.P., Harmey J.H., Kay E., Da Costa M., Redmond H.P., Bouchier-Hayes D.J. The role of endotoxin/lipopolysaccharide in surgically induced tumour growth in a murine model of metastatic disease. Br. J. Cancer. 1999, 81:1311-1317.
16. Molteni M., Marabella D., Orlandi C., Rossetti C. Melanoma cell lines are responsive in vitro to lipopolysaccharide and express TLR-4. Cancer Lett. 2006, 235:75-83.
17. Geng H., Zhang G.M., Xiao H., Yuan Y., Li D., Zhang H., Qiu H., He Y.F., Feng Z.H. HSP70 vaccine in combination with gene therapy with plasmid DNA encoding sPD-1 overcomes immune resistance and suppresses the progression of pulmonary metastatic melanoma. Int. J. Cancer. 2006, 118:2657-2664.
18. Liu Y., Huang B., Yuan Y., Gong W., Xiao H., Li D., Yu Z.R., Wu F.H., Zhang G.M., Feng Z.H. Inhibition of hepatocarcinoma and tumor metastasis to liver by gene therapy with recombinant CBD-HepII polypeptide of fibronectin. Int. J. Cancer 2007, 121:184-192.
19. Liu Q., Chen T., Chen H., Zhang M., Li N., Lu Z., Ma P., Cao X. Triptolide (PG-490) induces apoptosis of dendritic cells through sequential p38 MAP kinase phosphorylation and caspase 3 activation. Biochem. Biophys. Res. Commun. 2004, 319:980-986.
20. Huang B., Lei Z., Zhang G.M., Li D., Song C., Li B., Liu Y., Yuan Y., Unkeless J., Xiong H., Feng Z.H. SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. Blood 2008, 112:1269-1279.
21. Asea A., Rehli M., Kabingu E., Boch J.A., Bare O., Auron P.E., Stevenson M.A., Calderwood S.K. Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J. Biol. Chem. 2002, 277:15028-15034.
22. Yang H., Zhou H., Feng P., Zhou X., Wen H., Xie X., Shen H., Zhu X. Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion. J. Exp. Clin. Cancer Res. 2010, 10:29-92.
23. Youn H.S., Lee J.Y., Fitzgerald K.A., Young H.A., Akira S., Hwang D.H. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex. J. Immunol. 2005, 175:3339-3346.
24. Lee C.H., Jeon Y.T., Kim S.H., Song Y.S. NF-kappaB as a potential molecular target for cancer therapy. Biofactors 2007, 29:19-35.
25. 2-induced apoptosis via calcineurin pathways. J. Bioenergy Biomembr. 2007, 39:186-194.
26. Mosser D.D., Morimoto R.I. Molecular chaperones and the stress of oncogenesis. Oncogene 2004, 23:2907-2918.
27. Johnson J.D., Fleshner M. Releasing signals, secretory pathways, and immune function of endogenous extracellular heat shock protein 72. J. Leukoc. Biol. 2006, 79:425-434.
28. Chen T., Guo J., Han C., Yang M., Cao X. Heat shock protein 70, released from heat-stressed tumor cells, initiates antitumor immunity by inducing tumor cell chemokine production and activating dendritic cells via TLR4 pathway. J. Immunol. 2009, 182:1449-1459.
29. Tsan M.F. Toll-like receptors, inflammation and cancer. Semin. Cancer Biol. 2006, 16:32-37.
30. Wu C.X., Sun H., Liu Q., Guo H., Gong J.P. LPS induces HMGB1 relocation and release by activating the NF-kB-CBP signal transduction pathway in the murine macrophage-like cell line RAW264.7. J. Surg. Res. 2011, 17:1-13.
31. Ellerman J.E., Brown C.K., de Vera M., Zeh H.J., Billiar T., Rubartelli A., Lotze M.T. Masquerader: high mobility group box-1 and cancer. Clin. Cancer Res. 2007, 13:2836-2848.
32. Wu F.H., Yuan Y., Li D., Lei Z., Song C.W., Liu Y.Y., Li B., Huang B., Feng Z.H., Zhang G.M. Endothelial cell-expressed Tim-3 facilitates metastasis of melanoma cells by activating the NF-κB pathway. Oncol. Rep. 2010, 24:693-699.
33. van Beijnum J.R., Buurman W.A., Griffioen A.W. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1). Angiogenesis 2008, 11:91-99.
34. Brach M.A., Hass R., Sherman M.L., Gunji H., Weichselbaum R., Kufe D. Ionizing radiation induces expression and binding activity of the nuclear factor kappa B. J. Clin. Invest. 1991, 88:691-695.
35. Arlt A., Gehrz A., Muerkoster S., Vorndamm J., Kruse M.L., Folsch U.R., Schafer H. Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death. Oncogene 2003, 22:3243-3251.
36. Chendil D., Ranga R.S., Meigooni D., Sathishkumar S., Ahmed M.M. Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3. Oncogene 2004, 23:1599-1607.
37. Cusack J.C.Jr., Liu R., Houston M., Abendroth K., Elliott P.J., Adams J., Baldwin A.S. Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-kappaB inhibition. Cancer Res. 2001, 61:3535-3540.